Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

santenpharma

Santen Pharmaceutical says eye allergy drug meets primary endpoints in Phase III trials

May 11, 2016 Research and Development, Sales and Marketing Eye Allergy, Santen Pharmaceutical, drug trial, phase III

Santen Pharmaceutical said late stage trials for its drug to treat an allergic eye condition in children met its primary …
News
allergan

Allergan to buy back $10 billion of stock, Q1 earnings rise

May 11, 2016 Research and Development, Sales and Marketing Allergan, Buy Back, Financial, Q1, earnings, results, revenue

Botox-maker Allergan (NYSE: AGN) said it plans to buy back as much as $10 billion in stock after completing the …
News
fda2outsideweb

FDA expands Imbruvica label with new survival data

May 11, 2016 Research and Development, Sales and Marketing AbbVie, FDA, Janssen, data, efficacy, expanded, imbruvica, label, late stage, phase III

The US Food and Drug Administration (FDA) has expanded the label of Imbruvica (ibrutinib) to include the data from recent …
News
incyte

Incyte acquires Ariad’s European operations in $140 million deal

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Ariad, Incyte, Operations, buy out, european, iclusig, leukaemia, out-license

Incyte (NASDAQ: INCY) has entered into an agreement with Ariad Pharmaceuticals (NASDAQ: ARIA) that will see the company acquire Ariad’s …
News
celltherapy

Cell Therapy signs £12.5 million licensing deal with Daiichi Sankyo for heart failure treatment

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo, Deals, cell therapy, heart failure, licensing

UK-based Cell Therapy on Tuesday said it has signed a £12.5 million licensing deal with Japan’s Daiichi Sankyo (TYO: 4568) …
News
medivation

Medivation maybe mulling sale as bidding race heats up – Reports

May 10, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Amgen, Deals, M&A, MA, Medivation, Pfizer, Sanofi

Cancer drugmaker Medivation (Nasdaq: MDVN) is evaluating a potential sale following the recent string of offers from big pharma firms, …
News

China evaluating investigations into pharma firms to take on drug pricing issue

May 9, 2016 Business Services, Research and Development, Sales and Marketing China, France, G7, regulation

Lawmakers globally have acknowledged the concerns over unbridled drug costs as regulators stress the need for a more open debate …
News
abpi_reception_right

UK pharma would benefit by remaining in EU, says ABPI

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Andrew Witty, EU, brexit, letter, observer, pascal soriot, remain, stay

With the EU vote approaching, the Association of the British Pharmaceutical Industry (ABPI) has brought together 93 signatories, including the …
News
shutterstock_67313209

Focus: Governments evaluate policies, reforms as drug pricing debate rages on

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

By Anjali Shukla Lawmakers in France are set to urge the leaders of G7 countries to put in place guidelines …
Feature
hold_heart

Chiesi set to acquire Medicine Co cardiovascular assets, say reports

May 9, 2016 Sales and Marketing Chiesi, assets, cardiovascular, medicine co

Italian pharmaceutical company Chiesi are set to expand their global footprint as it nears an agreement to acquire Medicines Co’s …
News
stocks3

Endo shares plunge almost 40% as company cuts FY outlook

May 9, 2016 Sales and Marketing Endo International, earnings, outlook, revenue

Shares in Endo International (Nasdaq: ENDP) plunged to close down nearly 40% after the company cut its full-year earnings forecast …
News
needles

BTG acquires promising oncology pipeline in Galil Medical takeover

May 9, 2016 Manufacturing and Production, Research and Development, Sales and Marketing $84 million, BTG, cryoablation, galil medical, oncology, takeover

BTG (LSE: BTG) has announced that is has agreed to acquire Galil Medical, a leading provider of cryoablation products for …
News
allergan

Phase III trial meets primary endpoint for Allergan’s fibroid treatment

May 9, 2016 Manufacturing and Production, Research and Development, Sales and Marketing Allergan, fibroid, phase 3, phase III, ulipristal, ulipristal acetate, uterine fibroid

Allergan (NYSE: AGN), in collaboration with Gedeon Richter, has announced positive results from a pivotal Phase III trial evaluating the …
News
stocks1

Weekly Movers: Bind Therapeutics, Sarepta, Idexx…

May 9, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer (NYSE: PFE) and Amgen (Nasdaq: AMGN) are rumoured to be considering a bid for Medivation just as French drug …
Feature
stocks2

Clovis cuts staff by 35% after FDA knock back on lung cancer drug

May 6, 2016 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Q1 results, clovis, failure, job cuts, job losses, rociletinib, workforce

Clovis Oncology (NASDAQ: CLVS) is set to cut up to 35% of its workforce following the US Food and Drug …
News
The Gateway to Local Adoption Series

Latest content

IsomAb appoints Philip Brainin as CEO

March 19, 2026

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026

Qlaris Bio appoints Fred Guerard as President and CEO

March 18, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

March 18, 2026

AEON Biopharma appoints John Bencich as CFO

March 17, 2026